BACKGROUND: Surveying volunteer members of a multiple sclerosis registry is a very cost-effective way of assessing the impact of the disease on life outcomes. However, whether the data from such a study can be generalised to the whole population of persons living with MS in a country or region is unclear. METHODS: Here we compare the demographic and disease characteristics of participants in one such study, the Australian Multiple Sclerosis Longitudinal Study (AMSLS), with two well-characterised MS prevalence studies with near-complete ascertainment of MS in their study regions. RESULTS: Although some differences were found, these largely represented the effects of geography (sex ratios) and local factors (national immunomodulatory therapy prescribing requirements), and the cohorts were otherwise comparable. Overall, despite comprising only 12-16% of MS cases in Australia, the AMSLS is highly representative of the MS population. CONCLUSIONS: Therefore with some minor caveats, the AMSLS data can be generalised to the whole Australasian MS population. Volunteer disease registries such as this can be highly representative and provide an excellent convenience sample when studying rare conditions such as MS.
BACKGROUND: Surveying volunteer members of a multiple sclerosis registry is a very cost-effective way of assessing the impact of the disease on life outcomes. However, whether the data from such a study can be generalised to the whole population of persons living with MS in a country or region is unclear. METHODS: Here we compare the demographic and disease characteristics of participants in one such study, the Australian Multiple Sclerosis Longitudinal Study (AMSLS), with two well-characterised MS prevalence studies with near-complete ascertainment of MS in their study regions. RESULTS: Although some differences were found, these largely represented the effects of geography (sex ratios) and local factors (national immunomodulatory therapy prescribing requirements), and the cohorts were otherwise comparable. Overall, despite comprising only 12-16% of MS cases in Australia, the AMSLS is highly representative of the MS population. CONCLUSIONS: Therefore with some minor caveats, the AMSLS data can be generalised to the whole Australasian MS population. Volunteer disease registries such as this can be highly representative and provide an excellent convenience sample when studying rare conditions such as MS.
Entities:
Keywords:
Outcome measurement; multiple sclerosis; study design
Authors: Todd A Hardy; John Parratt; Heidi Beadnall; Stefan Blum; Richard Macdonell; Roy G Beran; Neil Shuey; Andrew Lee; William Carroll; Cameron Shaw; Richard Worrell; Jana Moody; Mamdouh Sedhom; Michael Barnett; Steve Vucic Journal: BMJ Neurol Open Date: 2022-07-04
Authors: Amber R Salter; Ruth Ann Marrie; Neetu Agashivala; Daniel A Belletti; Edward Kim; Gary R Cutter; Stacey S Cofield; Tuula Tyry Journal: Patient Prefer Adherence Date: 2014-07-04 Impact factor: 2.711
Authors: Dianne Currier; Jane Pirkis; John Carlin; Louisa Degenhardt; Shyamali C Dharmage; Billie Giles-Corti; Ian Gordon; Lyle Gurrin; Jane Hocking; Anne Kavanagh; Louise A Keogh; Rachel Koelmeyer; Anthony D LaMontagne; Marisa Schlichthorst; George Patton; Lena Sanci; Matthew J Spittal; David M Studdert; Joanne Williams; Dallas R English Journal: BMC Public Health Date: 2016-10-31 Impact factor: 3.295
Authors: Isabelle Weld-Blundell; Lisa Grech; Ron Borland; Sarah L White; Roshan das Nair; Claudia H Marck Journal: BMJ Open Date: 2022-07-29 Impact factor: 3.006